Forbes x Unicycive Therapeutics

Forbes highlighted Dr. Gupta’s cross-disciplinary background as a clinician, Wall Street researcher, and biotech founder.

He said that mix shapes Unicycive Therapeutics’ strategy to address major unmet needs in kidney care.

Dr. Gupta emphasized early physician collaboration, strong culture, and accountability as key to successful commercialization.

He also said AI can automate administrative work, improve clinician efficiency, and reduce friction across healthcare operations.